Shopping Cart
Remove All
Your shopping cart is currently empty
PD-1/PD-L1-IN-43 (Compound Z13) is a small molecule inhibitor that specifically targets the interaction between PD-1 and PD-L1. It exhibits significant in vivo antitumor activity against B16-F10 melanoma. By disrupting the interaction between PD-1 and PD-L1, PD-1/PD-L1-IN-43 effectively inhibits tumor growth and is applicable in antitumor research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PD-1/PD-L1-IN-43 (Compound Z13) is a small molecule inhibitor that specifically targets the interaction between PD-1 and PD-L1. It exhibits significant in vivo antitumor activity against B16-F10 melanoma. By disrupting the interaction between PD-1 and PD-L1, PD-1/PD-L1-IN-43 effectively inhibits tumor growth and is applicable in antitumor research. |
| In vitro | PD-1/PD-L1-IN-43 (0 - 20 μM; 48 h) activates immunosuppressed Jurkat T cells, enabling them to kill HepG2 cells in a co-culture system. |
| In vivo | PD-1/PD-L1-IN-43 (administered at 20 and 40 mg/kg via intraperitoneal injection, once daily for 2 weeks) effectively inhibits tumor growth in male C57BL/6J mice by activating the tumor immune microenvironment. |
| Formula | C27H25N3O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.